Evidence map›Paper›PMID 37795395›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology2023

Moderately hypofractionated post-operative radiation therapy for breast cancer: preferences amongst radiation oncologists from countries in Latin America and the Caribbean.

Gustavo Nader Marta, Fabio Y Moraes, Rejane Carolina de Oliveira Franco, Heloísa de Andrade Carvalho, André Guimaraes Gouveia, Gustavo Cartaxo de Lima Gössling, Rafaela Gomes de Jesus, Gustavo Ferraris, Pablo Munoz Schuffenegger, Gustavo Sarria Bardales and 22 more

Open access · diamondAbstract read
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 10 countries.

Gustavo Nader MartaDepartment of Radiation Oncology, Hospital Sírio-Libanês, Sao Paulo, Brazil.
Fabio Y MoraesLatin American Cooperative Oncology Group (LACOG), Brazil.
Rejane Carolina de Oliveira FrancoGerald Bronfman Department of Oncology - Radiation Oncology Department - McGill University, Canada.
Heloísa de Andrade CarvalhoLatin American Cooperative Oncology Group (LACOG), Brazil.
André Guimaraes GouveiaLatin American Cooperative Oncology Group (LACOG), Brazil.
Gustavo Cartaxo de Lima GösslingLatin American Cooperative Oncology Group (LACOG), Brazil.
Rafaela Gomes de JesusLatin American Cooperative Oncology Group (LACOG), Brazil.
Gustavo FerrarisCentro Radioterapia Dean Funes, Córodoba, Argentina.
Pablo Munoz SchuffeneggerLatin American Cooperative Oncology Group (LACOG), Brazil.
Gustavo Sarria BardalesInstituto Nacional Enfermedades Neoplásicas, Peru.
María Adela Poitevin ChacónMedica Sur, Radiation Oncology Department, Mexico.
Raúl MurilloCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogota, Colombia.
Luis Ernesto Moreno SánchezInstituto Nacional del Cáncer Rosa De Tavares (INCART), Savia Care Centro Avanzado de Radioterapia, Centro Gamma Knife Dominicano, Dominican Republic.
Elizabeth Gamarra-CabezasDepartamento de Radio-Oncología, Instituto Oncológico Nacional "Dr. Juan Tanca Marengo".
Arthur Accioly RosaLatin American Cooperative Oncology Group (LACOG), Brazil.
Maurício Fraga da SilvaLatin American Cooperative Oncology Group (LACOG), Brazil.
Marcos Duarte de MattosBarretos Cancer Hospital.
Diego Chaves Rezende MoraisLatin American Cooperative Oncology Group (LACOG), Brazil.
Douglas Guedes de CastroLatin American Cooperative Oncology Group (LACOG), Brazil.
Alan Dal PraLatin American Cooperative Oncology Group (LACOG), Brazil.
Beatriz E AmêndolaInnovative Cancer Institute, South Miami, United States.
José Máximo BarrosLatin American Cooperative Oncology Group (LACOG), Brazil.
Tomas Merino LaraDepartment of Hematology Oncology, school of Medicine, Pontificia Universidad Catolica de Chile, Chile.
Nicolás IsaClinica IRAM, Santiago de Chile, Chile.
Dolores de la Mata MoyaLatin American Cooperative Oncology Group (LACOG), Brazil.
Iván HidalgoCentro Javeriano de Oncología - Hospital Universitario San Ignacio, Colombia.
Diego Gimenez VelillaInstituto Nacional del Cáncer INCAN Paraguay.
Lijia Elizabeth Avilés LoayzaOncoservice, Bolivia.
Francisco Gomez MontenegroRadiation Oncology Department- Instituto Oncológico Nacional de Panamá, Panama.
Nestor O Sanchez ChacinRadiation therapy Service, Instituto Medico San Nicolas, Aruba.
Gustavo WerutskyLatin American Cooperative Oncology Group (LACOG), Brazil.
Gustavo Arruda VianiLatin American Cooperative Oncology Group (LACOG), Brazil.
Pontificia Universidad Católica de Chile · CLUniversidade de São Paulo · BRUniversity of Miami · USAC Camargo Hospital · BRAsociación Colombiana de Gastroenterología · COCentro Médico ABC · MXEastern Cooperative Oncology Group · USHospital de Câncer de Barretos · BRHospital Médica Sur · MXHospital Sírio-Libanês · BRHospital Universitario Austral · ARHospital Universitario San Ignacio · COInstituto de Radiomedicina · CLInstituto Nacional de Enfermedades Neoplásicas · PEInstituto Nacional del Cáncer · CLJuravinski Cancer Centre · CAMcGill University · CANational Oncologic Institute · PAQueen's University · CAUniversity of Aruba · AW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The safety and effectiveness of moderately hypofractionated post-operative radiation therapy for breast cancer were demonstrated by several trials. This study aimed to evaluate the current patterns of practice and prescription preference about moderately hypofractionated post-operative radiation therapy to assess possible aspects that affect the decision-making process regarding the use of fractionation in breast cancer patients in Latin America and the Caribbean (LAC). We also aimed to identify factors that can restrain the utilization of moderately hypofractionated post-operative radiation therapy for breast cancer. Materials an methods: Radiation oncologists from LAC were invited to contribute to this study. A 38-question survey was used to evaluate their opinions. Results: A total of 173 radiation oncologists from 13 countries answered the questionnaire. The majority of respondents (84.9%) preferred moderately hypofractionated post-operative radiation therapy as their first choice in cases of whole breast irradiation. Whole breast plus regional nodal irradiation, post-mastectomy (chest wall and regional nodal irradiation) without reconstruction, and post-mastectomy (chest wall and regional node irradiation) with reconstruction hypofractionated post-operative radiation therapy was preferred by 72.2% 71.1%, and 53.7% of respondents, respectively. Breast cancer stage, and flap-based breast reconstruction were the factors associated with absolute contraindications for the use of hypofractionated schedules. Conclusion: Even though moderately hypofractionated post-operative radiation therapy for breast cancer is considered a new standard to the vast majority of the patients, its unrestricted application in clinical practice across LAC still faces reluctance.

Indexed as

breast cancermoderately hypofractionatedradiation therapy

Identifiers

PMID37795395
PMCPMC10547413
OpenAlexW4387170990

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.